Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2003 | 1 |
2008 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Oral silibinin inhibits in vivo human bladder tumor xenograft growth involving down-regulation of survivin.
Clin Cancer Res. 2008 Jan 1;14(1):300-8. doi: 10.1158/1078-0432.CCR-07-1565.
Clin Cancer Res. 2008.
PMID: 18172282
Recently, we observed the in vitro efficacy of silibinin, a flavanolignan, in human bladder transitional cell papilloma RT4 cells. Here, we investigated the antitumor efficacy and associated mechanisms of silibinin in RT4 tumor xenograft. ...
Recently, we observed the in vitro efficacy of silibinin, a flavanolignan, in human bladder transitional cell papilloma …
The Drake Health Registry Study: findings from fifteen years of continuous bladder cancer screening.
Marsh GM, Cassidy LD.
Marsh GM, et al.
Am J Ind Med. 2003 Feb;43(2):142-8. doi: 10.1002/ajim.10166.
Am J Ind Med. 2003.
PMID: 12541268
Positive screens are eligible for a free bladder cystoscopy with random biopsies. RESULTS: Forty of 51 persons eligible for diagnostic evaluation underwent cystoscopy. One person was diagnosed with carcinoma in situ, two with transitional cell papilloma …
Positive screens are eligible for a free bladder cystoscopy with random biopsies. RESULTS: Forty of 51 persons eligible for diagnosti …
Item in Clipboard
Cite
Cite